Remove trial restrictions Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Merck
McKesson
Boehringer Ingelheim
Dow

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR LOFEXIDINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Lofexidine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000345 ↗ Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 Completed National Institute on Drug Abuse (NIDA) Phase 1 1996-04-01 The purpose of this study is to assess the safety of lofexidine in the treatment of opiate-dependent individuals.
NCT00000354 ↗ Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 Completed University of Pennsylvania Phase 1 1996-07-01 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000354 ↗ Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 Completed National Institute on Drug Abuse (NIDA) Phase 1 1996-07-01 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000358 ↗ Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 Completed University of Pennsylvania Phase 1 1969-12-31 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00000358 ↗ Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 Completed National Institute on Drug Abuse (NIDA) Phase 1 1969-12-31 The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
NCT00032942 ↗ Lofexidine for Opiate Withdrawal - 1 Completed Britannia Pharmaceuticals Ltd. Phase 3 2001-04-01 The purpose of this study is to evaluate lofexidine for opiate withdrawal.
NCT00032942 ↗ Lofexidine for Opiate Withdrawal - 1 Completed National Institute on Drug Abuse (NIDA) Phase 3 2001-04-01 The purpose of this study is to evaluate lofexidine for opiate withdrawal.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lofexidine Hydrochloride

Condition Name

Condition Name for Lofexidine Hydrochloride
Intervention Trials
Opioid Withdrawal 6
Opioid-Related Disorders 6
Opioid Dependence 5
Opioid-use Disorder 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lofexidine Hydrochloride
Intervention Trials
Opioid-Related Disorders 17
Substance Withdrawal Syndrome 9
Substance-Related Disorders 4
Disease 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lofexidine Hydrochloride

Trials by Country

Trials by Country for Lofexidine Hydrochloride
Location Trials
United States 86
Singapore 1
Israel 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lofexidine Hydrochloride
Location Trials
Texas 9
New York 9
California 7
Utah 6
Maryland 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lofexidine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Lofexidine Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 5
Phase 2/Phase 3 2
[disabled in preview] 28
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lofexidine Hydrochloride
Clinical Trial Phase Trials
Completed 28
Recruiting 5
Not yet recruiting 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lofexidine Hydrochloride

Sponsor Name

Sponsor Name for Lofexidine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 26
US WorldMeds LLC 19
New York State Psychiatric Institute 3
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lofexidine Hydrochloride
Sponsor Trials
NIH 27
Industry 22
Other 21
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Merck
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.